You are here

  • Home
  • Archive
  • Volume 68, Issue 6
  • Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Citation Tools

Article menu

This article has a correction. Please see:

Clinical and epidemiological research
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Keystone EC, Genovese MC, Klareskog L, et al
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
Annals of the Rheumatic Diseases 2009;68:789-796.